-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hematopoietic Stem Cell Maintenance

Program: Marquee Sessions
Session: E. Donnall Thomas Lecture and Prize
Monday, December 9, 2024, 9:00 AM-10:00 AM

Sean J. Morrison, PhD

Children’s Medical Center Research Institute at UT Southwestern, University of Texas Southwestern Medical Center, Dallas, TX

Disclosures: Morrison: Garuda Therapeutics: Consultancy, Current equity holder in private company; G1 Therapeutics: Current equity holder in publicly-traded company; Kojin Therapeutics: Consultancy, Current equity holder in private company.